Targeted Therapy Finder Advisors*

David Fisher MD PhD
David E Fisher MD PhD
Department of Dermatology
Harvard Medical School
Keith Flaherty MD
Keith T Flaherty MD
Department of
Medicine
Harvard Medical School

Learn the Science Behind the Targeted Therapy Finder

Science and the Melanoma Molecular Disease Model

XL518

Summary

Name(s) Target Manufacturer Status
XL518, GDC-0973 MEK Genentech In Phase I for solid tumors

Clinical Trials

Trial Status Phase
A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0973 in Combination With GDC-0941 When Administered Daily in Patients With Locally Advanced or Metastatic Solid Tumors [NCT00996892] Recruiting Phase 1
#